D. C. Malathi, K. Janakiraman, S. V. A. Thangavelu, and D. Ravichandran, “Enlicitide (Lipfendra): the first oral PCSK9 inhibitor - from macrocyclic peptide innovation to clinical translation”, Int J Basic Clin Pharmacol, vol. 15, no. 5, pp. 1126–1134, Aug. 2026.